Sirturo (Bedaquiline) tablets for the NIH (Notice of Intent to sole source)

The National Institutes of Health (NIH) Clinical Center is seeking to acquire Sirturo (Bedaquiline) tablets for patient care. The medication is required in two forms: 100 mg tablets in 188-count bottles and 20 mg tablets in 60-count bottles. The NIH expects to need approximately 12-36 bottles of each type per year. The acquisition will be sole-sourced to Cardinal Health, as they are the sole distributor of Sirturo in the U.S. • The medication is required for patient care at the NIH Clinical Center. • The acquisition will be sole-sourced to Cardinal Health. • The NIH expects to need approximately 12-36 bottles of each type per year. • The medication is supplied in two forms: 100 mg tablets in 188-count bottles and 20 mg tablets in 60-count bottles.